| Results summary | View all lists in GO:BiolProc | View all genes in G03D.profile.u50 |
anatomical structure development The biological process whose specific outcome is the progression of an anatomical structure from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome. enrichment: 1.57-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 207351_S_AT | SH2D2A | G | D | S | SH2 domain protein 2A | ||||||||
| 210512_S_AT | VEGFA | G | D | X | S | vascular endothelial growth factor A | |||||||
| 205842_S_AT | JAK2 | D | P | S | Janus kinase 2 (a protein tyrosine kinase) | ||||||||
| 203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
| 204203_AT | CEBPG | G | D | X | P | R | CCAAT/enhancer binding protein (C/EBP), gamma | ||||||
| 36711_AT | MAFF | D | R | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | |||||||||
| 212235_AT | PLXND1 | D | plexin D1 | ||||||||||
| 213792_S_AT | INSR | D | E | P | S | insulin receptor | |||||||
| 201324_AT | EMP1 | G | D | epithelial membrane protein 1 | |||||||||
| 205481_AT | ADORA1 | G | T | D | X | C | S | adenosine A1 receptor | |||||
| 206115_AT | EGR3 | D | R | C | early growth response 3 | ||||||||